17th annual eyeforpharma Philadelphia (Commercial, Digital and Patients)

Apr 16, 2019 - Apr 17, 2019, Philadelphia

800+ pharma leaders join together to discuss how to revolutionize the patient experience – and, accordingly, their commercial performance.

Philadelphia 2019: HCP Initiative Finalists Revealed

We have whittled it down to the final five. Here are the contenders for the Most Valuable HCP Initiative award

What makes our species so unique is our ability to spread ideas. This cross-pollination has enabled peace and prosperity to flourish, and ignorance to be supplanted by understanding.

Each of the innovative programs recognized in this year’s awards have made a meaningful contribution to improving people’s lives. Perhaps they have eased the burden on patients, or helped HCPs navigate the demands of their job, or entered a fruitful collaboration. Through sharing their ideas, we hope you too will be inspired.

The winner of the Most Valuable HCP Initiative award will be an innovative project designed to deliver tangible working and healthcare improvements both in the long and short term. Demonstrating understanding of real health requirements prior to implementation, the winning project will have been managed to an outstanding level and will have made an exceptionally positive impact on its intended customer.

Here are the finalists:

KCI Nurse2Nurse Social Community App
QooQoo, Inc

Wound care nurses are expected to make quick and correct therapy decisions for wound care patients, while also considering the thousands of therapy options at their disposal. Despite valuing and seeking the opinions and experiences of their peers, they often feel isolated in their clinical care setting.   

Nurse2Nurse is an app designed to remedy this. It is a semi-private community mobile application for nurses who work in wound care. Nurse2Nurse provides member nurses the ability to share vetted, trustworthy information one-to-one, one-to-some, or one-to-many with peers about wound care, patient and facility challenges, solutions, and more in an exclusive digital environment built by and for wound care nurses.  

Nurse2Nurse connects nurses to each other and to KCI in ways that extend beyond products, creating a moat around the brand and forging loyalties and new opportunities for potential sales and account expansion. The app also establishes KCI as a trusted industry partner for wound care education and resources.

The nursing community has been very receptive. At the time of reporting the app has 1,554 active members communicating with one another on a daily basis about therapy options, personal experiences and educational opportunities.  On average they spend 5 minutes in the app per active day and the community participation rate is 28%. The nurses enjoy engaging with peers about treatment choices, challenging wounds and patients, and new industry publications and events.

Here is what the customer is saying about the Nurse2Nurse app.

“We had 3 codes and two emergency surgeries. Unfortunately I did not have time to talk to the intensivist. That’s why this app is very helpful.” Karen, WOCN

“Fantastic app. Very good to debate cases. A lot of knowledgeable clinicians available to help every day.” Howard, RN


Doctors all over the world are caring for a growing number of patients with increasingly complex conditions. Equipping the physicians with medical evidence requires a new level of concierge service with ability to share tailored content (when, where, and how they prefer it) is critical to enabling doctors and nurses to care for – well – all of us.

This is why Sanofi developed MedVox – a medical engagement platform for sharing scientific content face-to-face, on demand, and/or remotely. Sanofi took a hard look at what pained the doctors themselves – and removed shuffling of papers, waiting for schedules, and technology barriers. Sanofi replaced them with custom-tailored conversations, speed, reach, and convenience.

It is important to note that medical engagements are centered on science: covering topics such as mechanisms of action, detailed data from clinical trials, metabolic processes, and so on. This is why doctors tend to provide significantly longer engagement time with field-based medical professionals, as they can focus on having the most up-to-date information for educated decisions with their patients.

To date, MedVox is in 27 countries, with over 900 of Sanofi Medical colleagues, and in over 6,000 engagements in less than 6 months. In just 12 months, MedVox will be available to doctors around the world – truly bringing us together in improving global health.

GRASP - Virtual Reality
Sanofi North America Diabetes and Cardiovascular Medical Affairs

Far from being a flash in the pan, virtual reality has proven to be a powerful tool for educating, inspiring and empathizing. It’s little wonder then that it is the perfect resource for educating HCPS.

New methods of educating HCPS are essential in order to advance scientific communications and Sanofi recognized the potential of VR to do just that.

The team developed an interactive VR experience that immerses the participants in a patient’s journey recovering from an Acute Coronary Syndrome (ACS). The experience includes a heart animation showing the formation of a clot with pre/post questions testing their knowledge of ACS guidelines utilizing hand-held remotes.

This VR activity was initially introduced within our organization to 400 Health Care Professionals across the Globe including Cardiologists, Endocrinologists and Lipidologists during a Diabetes and Cardiovascular Forum focusing on Medicine and Technology.  Greater than 100 individuals experienced the program leading to fruitful discussions with internal Medical Directors.

Ongoing implementation across the organization includes the use of the VR methodology within the Sanofi US Field Medical team as a tool to educate and evolve scientific exchange and interactions with HCPS.  Other areas within the organization that have been identified for potential expansion include Medical Information, Virtual Clinical Trial Recruitment, Value-based contracting, and Patient Reported Outcomes.

Clinical Advances in Major Depressive Disorder: Focus on Patient-Centered Care
Medscape Education

Nearly one in five adults in the U.S. suffer with major depressive disorder (MDD). Although a common, pervasive and serious disease, it remains underdiagnosed and undertreated – with significant quality of life and mental health consequences and an increased risk of morbidity and mortality from other serious conditions.   

To help close existing professional gaps in treating MDD, Medscape Education developed 20 Continuing Medical Education/Continuing Education (CME/CE)-certified educational activities and hosted them on a learning destination page dedicated to MDD.  The program was supported by an educational grant from Takeda Pharmaceuticals.

The education initiative reached and impacted over 166,000 healthcare providers in the United States and made notable improvements in the management of MDD.

Making Critical Moments Matter Between You and Your Doctor
Boehringer Ingelheim

It’s extremely important to take advantage of those far and few between moments that patients have with their doctor.  Digital point-of-care initiatives can enhance these meetings by providing relevant medical information in the context of a doctor’s office, pharmacy, or other location where health decisions are happening.  As best as possible, synchronizing delivery of that information to both patient and the doctor at the same moment is very important.

Boehringer Ingelheim and Aptus Health developed a multi-audience, geo-targeted, mobile campaign that successfully connects HCPs and their patients, helping them identify a therapy that is right for them. The brand’s incremental revenue significantly increased because of this innovative campaign.

This initiative enabled these most important moments to be more informed and impactful.  The technology allows for both the doctors and their patients to be aware of information about pertinent brands at a critical time and for this information to be delivered in an engaging, contextually relevant way.  The technology also allows for this offering to be scaled and enhanced.

Since its launch the initiative has successfully connected doctors and their patients and helped them identify the therapy that is right for them.  The evidence includes statistically significant increase in incremental brand revenue when comparing the performance of the 7,000 five-hundred-foot radius geodomes that received the mobile advertisements to matched controlled geodomes that did not received advertisements. 

Your exclusive opportunity to witness these, plus many other real world, successful case studies awaits! Find out more about the Awards Pitch Day North America here



17th annual eyeforpharma Philadelphia (Commercial, Digital and Patients)

Apr 16, 2019 - Apr 17, 2019, Philadelphia

800+ pharma leaders join together to discuss how to revolutionize the patient experience – and, accordingly, their commercial performance.